Stocksigma LogoStocksigma Logo

Sakar Healthcare Reports Strong Q2FY27 Results With 149% YoY PAT Surge

Sakar Healthcare reported robust Q2FY27 consolidated performance, with revenue from operations growing 52% YoY to ₹8,741.61 lakhs

Sakar Healthcare Reports Strong Q2FY27 Results With 149% YoY PAT Surge

Sakar Healthcare Ltd · Press Release · 26 Oct 2026, 7:30 pm

Sakar Healthcare Reports Strong Q2FY27 Results With 149% YoY PAT Surge Sakar Healthcare reported robust Q2FY27 consolidated performance, with revenue from operations growing 52% YoY to ₹8,741.61 lakhs. EBITDA jumped 114% YoY to ₹2,434.53 lakhs with margins expanding 800 bps to 28%, while PAT surged 149% YoY to ₹1,130.69 lakhs (13% margin), driven by favorable oncology mix and operational leverage. For H1FY27, revenue reached ₹16,038.86 lakhs and PAT stood at ₹2,159.18 lakhs. Growth was supported by commencement of commercial supplies from its EU-GMP approved oncology site, 69 executed contracts, and regulatory advancements.

Original exchange filing (PDF)

More announcements from Sakar Healthcare Ltd

All Sakar Healthcare Ltd announcements